Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer

Press/Media

Period	Sep 14 2022

Media coverage

Title	Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer
Media name/outlet	Business Wire
Country/Territory	United States
Date	09/14/22
URL	www.businesswire.com/news/home/20220914005182/en/Lantern-Pharma-to-Present-Positive-Preclinical-Data-on-the-Efficacy-of-LP-184-for-Pancreatic-Cancer-at-the-AACR-Special-Conference-for-Pancreatic-Cancer/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT
Persons	Igor Astsaturov